Compounds > midazolam

midazolam and 1-hydroxymethylmidazolam glucuronide

midazolam has been researched along with 1-hydroxymethylmidazolam glucuronide in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	1 (16.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dirksen, MS; Driessen, JJ; Guelen, PJ; Hafkenscheid, JC; Janssen, TJ; Shimoda, M; Termond, EF; van Dalen, R; Vree, TB	1
Compas, D; de Goede, PN; Swart, EL; Touw, DJ; van Rij, KM	1
de Hoog, M; de Wildt, SN; van den Anker, JN; van der Giesen, E; Vinks, AA	1
de Hoog, M; de Wildt, SN; Joosten, KF; van den Anker, JN; van Dijk, M; Vinks, AA	1
Goh, BC; Hee, KH; Lee, LS; Sapari, NS; Seng, KY; Soon, GH; Soong, R	1
Baar, FPM; de Winter, BCM; Franken, LG; Koch, BCP; Masman, AD; Mathot, RAA; Tibboel, D; van Gelder, T	1

Trials

3 trial(s) available for midazolam and 1-hydroxymethylmidazolam glucuronide

Article	Year
Pharmacodynamics of midazolam in pediatric intensive care patients. Therapeutic drug monitoring, 2005, Volume: 27, Issue:1 Topics: Adolescent; Child; Child, Preschool; Conscious Sedation; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care, Neonatal; Midazolam; Patients; Time Factors	2005
CYP3A53 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients. Journal of clinical pharmacology, 2014, Volume: 54, Issue:2* Topics: Adult; Aged; Anti-Anxiety Agents; Asian People; Bilirubin; Body Weight; Creatinine; Cytochrome P-450 CYP3A; Female; Genotype; Glucuronosyltransferase; Humans; Injections, Intravenous; Male; Midazolam; Middle Aged; Neoplasms; Polymorphism, Genetic	2014
Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect? British journal of clinical pharmacology, 2017, Volume: 83, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Glomerular Filtration Rate; Humans; Hypnotics and Sedatives; Hypoalbuminemia; Injections, Subcutaneous; Male; Metabolic Clearance Rate; Midazolam; Middle Aged; Nonlinear Dynamics; Palliative Care; Precision Medicine; Renal Elimination; Terminally Ill; Time Factors	2017

Other Studies

3 other study(ies) available for midazolam and 1-hydroxymethylmidazolam glucuronide

Article	Year
Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients. Clinical pharmacology and therapeutics, 1989, Volume: 46, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Critical Care; Female; Humans; Infusions, Intravenous; Least-Squares Analysis; Male; Midazolam; Middle Aged; Protein Binding; Serum Albumin	1989
Reversed-phase ion-pair HPLC method for the direct analysis of 1-OH midazolam glucuronide in human serum. Therapeutic drug monitoring, 1999, Volume: 21, Issue:4 Topics: Calibration; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Midazolam; Reproducibility of Results; Sensitivity and Specificity	1999
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients. Critical care medicine, 2003, Volume: 31, Issue:7 Topics: Adolescent; Aryl Hydrocarbon Hydroxylases; Bayes Theorem; Child; Child, Preschool; Conscious Sedation; Critical Care; Cytochrome P-450 CYP3A; Female; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Liver Failure; Male; Mathematical Computing; Metabolic Clearance Rate; Midazolam; Oxidoreductases, N-Demethylating; Renal Insufficiency	2003